SCHEMBL22917201

SCHEMBL22917201

CC(=O)C(c1ccccc1)c1cccc(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ACP3 P15309 1/20 0.51
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
TRPM8 Q7Z2W7 3/20 0.45
CTSB P07858 1/20 0.43
LMNA P02545 2/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
GPR139 Q6DWJ6 2/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
RECQL P46063 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ATM Q13315 1/20 0.42
CACNA1G O43497 1/20 0.42
CACNA2D1 P54289 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22917154 0.94 ACP3 (0.47) MEN1KMT2AACP3ALDH1A1HPGD
SCHEMBL17504249 0.91 BRD4 (0.49) MEN1KMT2AACP3ALDH1A1HPGD
SCHEMBL22917146 0.86 TRPM8 (0.44) MEN1KMT2AACP3TRPM8LMNA
SCHEMBL7966754 0.85 MEN1 (0.59) MEN1KMT2AACP3ALDH1A1HPGD
SCHEMBL22917155 0.85 HDAC4 (0.53) MEN1KMT2AACP3RAB9A
SCHEMBL12495860 0.83 ALDH1A1 (0.48) MEN1KMT2AACP3ALDH1A1HPGD
SCHEMBL28419252 0.83 BRD4 (0.55) MEN1KMT2AHTTTDP1L3MBTL1
Benzene SCHEMBL27414119 0.82 L3MBTL1 (0.56) KMT2AALDH1A1HPGDLMNAMAPK1
SCHEMBL396389 0.82 L3MBTL1 (0.56) KMT2AALDH1A1HPGDLMNAMAPK1
SCHEMBL23031986 0.81 MEN1 (0.52) MEN1KMT2AACP3ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3770148-A1 RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2021-01-27 EP disclosed